Sexual dysfunction from serotonin reuptake inhibitors is a common occurrence. It is thought that this side effect might diminish over time. Our study of 132 medication trials in 97 patients found that 9.8% of the trials demonstrated accommodation to SRI-induced sexual dysfunction. Practitioners who utilize the strategy of waiting for spontaneous remission of this side effect should be aware that accommodation appears to be an uncommon phenomenon.